Bacteremic pneumococcal pneumonia: A prospective study in Edmonton and neighboring municipalities

Medicine

Volumn 84, Issue 3, 2005, Pages 147-161

  Shariatzadeh, Mohammed Reza ^a   Huang, Jane Q ^a   Tyrrell, Gregory J ^a,b   Johnson, Marcia M ^c   Marrie, Thomas J ^a,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^c Capital Health Edmonton   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; OFLOXACIN; OXACILLIN; PENICILLIN G; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CANADA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOMELESSNESS; HUMAN; INTENSIVE CARE UNIT; LOBAR PNEUMONIA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREGNANCY; PRIORITY JOURNAL; PRISON; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CANADA; FEMALE; HOMELESS PERSONS; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRISONERS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 18744376296     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000164302.03972.d7     Document Type: Article

References (55)

1. Adams HG, Jordan C. Infections in the alcoholic. Med Clin North Am. 1984;68:179-200.
2. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 1964;60:759-776.
3. Baddour LM, Yu VL, Klugman KP, Feldman C, Ortqvist A, Rello J, Morris AJ, Luna CM, Snydman DR, Ko WC, Chedid MB, Hui DS, Andremont A, Chiou CCC; International Pneumococcal Study Group. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med. 2004;170:440-444.
4. Bennett NM, Buffington J, LaForce FM. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health. 1992;82:1513-1516.
5. Berkowitz K, LaSala A. Risk factors associated with the increasing prevalence of pneumonia during pregnancy. Am J Obstet Gynecol. 1990;163:981-985.
6. Bierer MF. Homelessness: a national perspective. [Book review of Robertson MJ, Greenblatt M, eds. Homelessness: A National Perspective. (Topics in Social Psychiatry.) New York: Plenum; 1992.] N Engl J Med. 1993;328:892.
7. Brandenburg JA, Marrie TJ, Coley CM, Singer DE, Obrosky DS, Kapoor WN, Fine MJ. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia. J Gen Intern Med. 2000;15:638-646.
8. Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990 - ethnic differences and opportunities for prevention. J Infect Dis. 1994;170:368-376.
9. Davidson R, Low DE, Canadian Bacterial Surveillance Network. A cross-Canada surveillance of antimicrobial resistance in respiratory tract pathogens. Can J Infect Dis. 1999;10:128-133.
10. Dominguez A, Salleras L, Cardenosa N, Ciruela P, Carmona G, Martinez A, Torner N, Fuentes M. The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). Vaccine. 2002;20:2989-2994.
11. Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax. 1994;49:825-834.
12. Fainstein V, Musher DM. Bacterial adherence to pharyngeal cells in smokers, non-smokers, and chronic bronchitics. Infect Immun. 1979;26:178-182.
13. Felmingham D, Feldman C, Hryniewicz W, et al. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect. 2002;8(Suppl 2):12-42.
14. File TM Jr, Mandell LA. What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia? Clin Infect Dis. 2003;36:396-398.
15. Filice GA, Darby CP, Fraser DW. Pneumococcal disease in Charleston County, South Carolina. Am J Epidemiol. 1980;112:828-835.
16. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-250.
17. Flamaing J, Verhaegen J, Peetermans WE. Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population and implications for vaccine use. J Antimicrob Chemother. 2002;50:43-50.
18. Gentry MJ. Pneumococcal pneumonia in alcoholism and HIV infection. Alcohol Clin Exp Res. 1998;22(Suppl 5):201S-203S.
19. Green GM, Carolin D. The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages. N Engl J Med. 1967;276:421-427.
20. Halm EA, Atlas SJ, Borowsky LH, Benzer TI, Metlay JP, Chang YC, Singer DE. Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors. Arch Intern Med. 2000;160:98-104.
21. Halm EA, Teirstein AS. Management of community-acquired pneumonia. N Engl J Med. 2002;347:2039-2045.
22. Henriques B, Kalin M, Ortqvist A, Olsson Liljequist B, Almela M, Marrie TJ, Mufson MA, Torres A, Woodhead MA, Svenson SB, Kallenius G. Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis. 2000;182:833-839.
23. Hoge CW, Reichler MR, Dominguez EA, Bremer JC, Mastro TD, Hendricks KA, Musher DM, Elliott JA, Facklam RR, Breiman RF. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med. 1994;331:643-648.
24. Hook EW 3rd, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA. 1983;249:1055-1057.
25. Janoff EN, Rubins JB. Invasive pneumococcal disease in the immunocompromised host. Microb Drug Resist. 1997;3:215-232.
26. Kalin M, Ortqvist A, Almela M, Aufwerber E, Dwyer R, Henriques B, Jorup C, Julander I, Marrie TJ, Mufson MA, Riquelme R, Thalme A, Torres A, Woodhead MA. Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis. 2000;182:840-847.
27. Karstaedt AS, Khoosal M, Crewe-Brown HH. Pneumococcal bacteremia during a decade in children in Soweto, South Africa. Pediatr Infect Dis J. 2000;19:454-457.
28. Knaus WA, Wagner DP, Loirat P, Cullen DJ, Glaser P, Mercier P, Nikki P, Snyder JV, Le Gall JR, Draper EA, Campos RA, Kohles MK, Granthil C, Nicolas F, Shin B, Wattel F, Zimmerman JE. A comparison of intensive care in the U.S.A. and France. Lancet. 1982;320:642-646.
29. Knaus WA, Draper EA, Wagner DP, Zimmerman JE, Birnbaum ML, Cullen DJ, Kohles MK, Shin B, Snyder JV. Evaluating outcome from intensive care: a preliminary multihospital comparison. Crit Care Med. 1982;10:491-496.
30. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
31. Liu YK. Effects of alcohol on granulocytes and lymphocytes. Semin Hematol. 1980;17:130-136.
32. Marrie TJ, Low DE, de Carolis E; Canadian Community-Acquired Pneumonia Investigators. A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology - results from a Canadian multicentre study. Can Respir J. 2003;10:368-374.
33. Mercat A, Nguyen J, Dautzenberg B. An outbreak of pneumococcal pneumonia in two men's shelters. Chest. 1991;99:147-151.
34. Moss M. The role of alcohol in severe pneumonia and acute lung injury. In: Rello J, Leeper KV, eds. Severe Community Acquired Pneumonia. Boston: Kluwer Academic Publishers; 2001:119-137.
35. Mufson MA, Oley G, Hughey D. Pneumococcal disease in a medium-sized community in the United States. JAMA. 1982;248:1486-1489.
36. Mufson MA, Stanek RJ. Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978-1997. Am J Med. 1999;107:34-43.
37. Musher DM, Alexandraki I, Graviss EA, Yanbeiy N, Eid A, Inderias L, Phan H M, Solomon E. Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study. Medicine (Baltimore). 2000;79:210-221.
38. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 5th ed. NCCLS approved standard M7-A5. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
39. Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, Breiman RF, for The Active Bacterial Core Surveillance Team. Cigarette smoking and invasive pneumococcal disease. N Engl J Med. 2000;342:681-689.
40. Ortqvist A, Julander I, Lejdeborn L, Lundberg L. Diagnostic fiberoptic bronchoscopy, and protected brush culture in patients with community-acquired pneumonia. Chest. 1990;97:576-582.
41. Perlino CA, Rimland D. Alcoholism, leukopenia, and pneumococcal sepsis. Am Rev Respir Dis. 1985;132:757-760.
42. Plouffe JF, Breiman RF, Facklam RR, for the Franklin County Pneumonia Study Group. Bacteremia with Streptococcus pneumoniae. JAMA. 1996;275:194-198.
43. Raman AS, Swinburne AJ, Fedullo AJ. Pneumococcal adherence to the buccal epithelial cells of cigarette smokers. Chest. 1983;83:23-27.
44. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, Zell ER, Schuchat A, Whitney CG, for the Active Bacterial Core Surveillance (ABCs)/Emerging Infection Program Network. Epidemiology of invasive Streptococcus pneumoniae infection in the United States, 1995-1998. JAMA. 2001;285:1729-1735.
45. Sankilampi U, Isoaho R, Bloigu A, Kivela S-L, Leinonen M. Effect of age, sex, and smoking habits on pneumococcal antibodies in an elderly population. Int J Epidemiol. 1997;26:420-427.
46. Schito GC, Marchese A, Elkharrat D, Farrell DJ, PROTEKT Study Group. Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study. J Chemother. 2004;16:13-22.
47. Scott JAG, Hall AJ, Dagan R, Dixon JMS, Eykyn SJ, Fenoll A, Mortal M, Jette LP, Jorgensen JH, Lamothe F, Latorre C, Macfarlane JT, Shlaes DM, Smart LE, Taunay A. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7000 episodes of invasive disease. Clin Infect Dis. 1996;22:973-981.
48. Spagnuolo PJ, MacGregor RR. Acute ethanol effect on chemotaxis and other components of host defense. J Lab Clin Med. 1975;86:24-31.
49. Tilghman RC, Finland M. Clinical significance of bacteremia in pneumococcal pneumonia. Arch Intern Med. 1937;59:602-619.
50. Tisman G, Herbert V. In vitro myelosuppression and immunosuppression by ethanol. J Clin Invest. 1973;52:1410-1414.
51. Tugwell P, Williams AO. Jaundice associated with lobar pneumonia. A clinical, laboratory and histological study. Q J Med. 1977;46:97-118.
52. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau CRN, Reingold A, Lefkowitz L, Cieslak PR, Cetron M, Zell ER, Stat M, Jorgensen JH, Schuchat A, for The Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917-1924.
53. Yu VL, Chiou CCC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MBF, Andremont A, Klugman KP, for the International Pneumococcal Study Group. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered and clinical outcome. Clin Infect Dis. 2003;37:230-237.
54. Zhanel GG, Karlowsky JA, Palatnick L, Vercaigne L, Low DE, Hoban DJ. Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group. Antimicrobial Agents Chemother. 1999;43:2504-2509.
55. Zimmerman HJ, Fang M, Utili R, Seeff LB, Hoofnagle J. Jaundice due to bacterial infection. Gastroenterology. 1979;77:362-374.